# PRODUCTION OF AMMONIUM TETRATHIOMOLIBDATE (ATTM) CAPSULES FOR USE IN CLINICAL TRIALS

> **NIH NIH N01** · IRISYS, INC. · 2022 · $413,130

## Abstract

PRODUCTION OF AN ENGINEERING BATCH, CGMP BATCH, DELIVERY, AND SHELF-LIFE STUDY OF AMMONIUM TETRATHIOMOLIBDATE (ATTM) CAPSULES FOR USE IN CLINICAL TRIALS

## Key facts

- **NIH application ID:** 10710311
- **Project number:** 75N98019D00058-0-759102200002-1
- **Recipient organization:** IRISYS, INC.
- **Principal Investigator:** ROBERT GIANNINI
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $413,130
- **Award type:** —
- **Project period:** 2022-03-08 → 2026-03-07

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10710311

## Citation

> US National Institutes of Health, RePORTER application 10710311, PRODUCTION OF AMMONIUM TETRATHIOMOLIBDATE (ATTM) CAPSULES FOR USE IN CLINICAL TRIALS (75N98019D00058-0-759102200002-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10710311. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*